| 1 | Energy | XLE | +26.1% |
| 2 | Technology | XLK | +18.6% |
| 3 | Industrials | XLI | +15.5% |
| 4 | Real Estate | XLRE | +13.9% |
| 5 | Materials | XLB | +13.5% |
| 6 | Consumer Staples | XLP | +12.1% |
| 7 | Healthcare | XLV | +7.6% |
| 8 | Utilities | XLU | +5.4% |
| 9 | Financials | XLF | +4.9% |
| 10 | Consumer Disc. | XLY | -5.0% |
| 11 | Communication | XLC | -6.2% |
Krystal Biotech Inc is an integrated, commercial-stage biotechnology company focused on the discovery, development, manufacturing, and commercialization of genetic medicines to treat diseases with high unmet medical needs. …
| Qtr | Date | EPS Est | Act | Δ | YoY | Rev Est | Act | Δ | YoY |
|---|---|---|---|---|---|---|---|---|---|
| Q2 '26 | 8/3/26 | $1.89 | — | — | — | $0.1B | — | — | — |
| Q1 '26 | 5/4/26 | $1.43 | $1.83 | +28.0% | +53% | $0.1B | $0.1B | +3.8% | +32% |
| Q4 '25 | 2/17/26 | $1.61 | $1.70 | +5.6% | +12% | $0.1B | $0.1B | +0.5% | +18% |
| Q3 '25 | 11/3/25 | $1.12 | $2.66 | +1.4% | +192% | $0.1B | $0.1B | +5.6% | +17% |
| Q2 '25 | 8/4/25 | $1.29 | $1.29 | 0.0% | +37% | $0.1B | $0.1B | +5.1% | +37% |
| Q1 '25 | 5/6/25 | $1.52 | $1.20 | -21.1% | +161% | $0.1B | $0.1B | -8.3% | +95% |